Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.3253 USD
−97.43 M USD
3.09 M USD
19.20 M
About Omega Therapeutics, Inc.
Sector
Industry
CEO
Kaan Certel
Website
Headquarters
Cambridge
Founded
2016
FIGI
BBG00WCNQZN4
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OMGA is 0.7760 USD — it has increased by 3.97% in the past 24 hours. Watch Omega Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Omega Therapeutics, Inc. stocks are traded under the ticker OMGA.
OMGA stock has fallen by −28.81% compared to the previous week, the month change is a −26.83% fall, over the last year Omega Therapeutics, Inc. has showed a −59.16% decrease.
We've gathered analysts' opinions on Omega Therapeutics, Inc. future price: according to them, OMGA price has a max estimate of 12.00 USD and a min estimate of 4.00 USD. Watch OMGA chart and read a more detailed Omega Therapeutics, Inc. stock forecast: see what analysts think of Omega Therapeutics, Inc. and suggest that you do with its stocks.
OMGA reached its all-time high on Nov 1, 2021 with the price of 31.4100 USD, and its all-time low was 0.7706 USD and was reached on Nov 15, 2024. View more price dynamics on OMGA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OMGA stock is 6.60% volatile and has beta coefficient of 1.27. Track Omega Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Omega Therapeutics, Inc. there?
Today Omega Therapeutics, Inc. has the market capitalization of 43.75 M, it has decreased by −21.76% over the last week.
Yes, you can track Omega Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Omega Therapeutics, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
OMGA earnings for the last quarter are −0.30 USD per share, whereas the estimation was −0.27 USD resulting in a −13.21% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about Omega Therapeutics, Inc. earnings.
Omega Therapeutics, Inc. revenue for the last quarter amounts to 2.61 M USD, despite the estimated figure of 700.00 K USD. In the next quarter, revenue is expected to reach 1.34 M USD.
OMGA net income for the last quarter is −16.44 M USD, while the quarter before that showed −16.30 M USD of net income which accounts for −0.85% change. Track more Omega Therapeutics, Inc. financial stats to get the full picture.
No, OMGA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 94.00 employees. See our rating of the largest employees — is Omega Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Omega Therapeutics, Inc. EBITDA is −66.84 M USD, and current EBITDA margin is −3.02 K%. See more stats in Omega Therapeutics, Inc. financial statements.
Like other stocks, OMGA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omega Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omega Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omega Therapeutics, Inc. stock shows the sell signal. See more of Omega Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.